专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2016040880A1 COMBINATION THERAPIES OF ALK INHIBITORS 审中-公开
标题翻译： ALK抑制剂的组合治疗
公开(公告)号：WO2016040880A1
公开(公告)日：2016-03-17
申请号：PCT/US2015/049810
申请日：2015-09-11
申请人： NOVARTIS AG , LEBWOHL, David , PETERS, Malte , LI, Nanxin , LAU, Yvonne , SCOTT, Jeffrey
发明人： LEBWOHL, David , PETERS, Malte , LI, Nanxin , LAU, Yvonne , SCOTT, Jeffrey
IPC分类号： A61K39/395 , A61K31/506 , C07K16/28 , A61P35/00
CPC分类号： A61K39/39558 , A61K9/0053 , A61K31/506 , A61K31/55 , A61K2039/505 , A61K2039/54 , A61K2039/542 , A61K2039/545 , C07K16/28 , C07K16/2803 , C07K16/2818 , C07K16/2827 , C07K16/3023 , C07K2317/21 , C07K2317/76 , A61K2300/00
摘要： A method of treating a cancer in a subject is disclosed, comprising administering to the subject an immunomodulator and a second therapeutic agent, wherein: (i) the immunomodulator is chosen from one or more of: an activator of a costimulatory molecule or an inhibitor of an immune checkpoint molecule, and (ii) the second therapeutic agent is LDK378, thereby treating the cancer..
摘要翻译：公开了一种治疗受试者的癌症的方法，包括对受试者施用免疫调节剂和第二治疗剂，其中：（i）所述免疫调节剂选自以下中的一种或多种：共刺激分子的活化剂或抑制剂免疫检查点分子，和（ii）第二治疗剂是LDK378，从而治疗癌症。

2. 发明申请

WO2002075399A1 MODULAR FIBER OPTIC SWITCH CORE 审中-公开
标题翻译：模块化光纤开关芯
公开(公告)号：WO2002075399A1
公开(公告)日：2002-09-26
申请号：PCT/US2002/008341
申请日：2002-03-19
申请人： C SPEED CORPORATION , GUPTA, Pavan , SCOTT, Jeffrey , CUSHMAN, William , BURKE, Elliot , SHRODE, Theodore
发明人： GUPTA, Pavan , SCOTT, Jeffrey , CUSHMAN, William , BURKE, Elliot , SHRODE, Theodore
IPC分类号： G02B6/26
CPC分类号： G02B6/357 , G02B6/32 , G02B6/3512 , G02B6/3556 , G02B6/3582 , G02B6/3644 , G02B6/3664 , G02B6/3672
摘要： An optical switching core (100) is disclosed that includes a plurality of input optical tiles (200(i)) and output optical tiles (200(o)) for directing optical beams between various input and output ports coupled to optical fibers. Each of the optical tiles includes a collimating optics array (210) for transmitting a plurality of incoming optical beams and a transparent beam directing array (220) optically coupled to said collimating optics array for redirecting said plurality of incoming optical. Two or more optical tiles are rotated about an optical axis with respect to one another to provide a compact, modular design. Drive electronics (290) may be incorporated on the tile or off of a tile. A method for fabricating a compact, modular switching core is also disclosed that enables the independent fabrication and testing of collimating optics and beam directing arrays and passive alignment of the same on a frame.
摘要翻译：公开了一种光学切换核心（100），其包括多个输入光瓦片（200（i））和输出光瓦片（200（o）），用于将光束引导到耦合到光纤的各种输入和输出端口之间。每个光瓦片包括用于传输多个入射光束的准直光学阵列（210）和光耦合到所述准直光学器件阵列的透明光束定向阵列（220），用于重定向所述多个入射光学器件。两个或更多个光瓦相对于彼此围绕光轴旋转以提供紧凑的模块化设计。驱动电子器件（290）可以并入瓷砖或瓷砖上。还公开了一种用于制造紧凑型模块化开关芯的方法，其使得能够独立地制造和测试准直光学元件和光束定向阵列，并使其在框架上的被动对准。

3. 发明申请

WO2010075320A1 TEST LOADING IN OFDMA WIRELESS NETWORKS 审中-公开
标题翻译：在OFDMA无线网络中的测试加载
公开(公告)号：WO2010075320A1
公开(公告)日：2010-07-01
申请号：PCT/US2009/069083
申请日：2009-12-21
申请人： NORTEL NETWORKS LIMITED , WOODLEY, Michael , SCOTT, Jeffrey , GOFF, Jeffrey
发明人： WOODLEY, Michael , SCOTT, Jeffrey , GOFF, Jeffrey
IPC分类号： H04W24/06
CPC分类号： H04W24/06 , H04L5/0007 , H04L5/003 , H04L5/0037 , H04L5/0046 , H04L5/0062 , H04L5/0091 , H04L5/0094 , H04W72/044 , H04W88/02
摘要： A radio frequency radio (RF) transceiver that defines scheduling logic for generating transmission schedules for orthogonal frequency-division multiple access (OFDMA) RF transmissions from the RF transceiver, wherein the scheduling logic specifies at least one of a modulation type, a code rate, a sub-channel, and a sub-carrier for a plurality of symbols to be transmitted in a communication signal sub-frame. A processor generates outgoing data bits and outgoing test data bits for transmission from the RF transceiver as OFDMA transmission signals and OFDMA test data transmission signals, respectively, according to the transmission schedules to create loading within at least a portion of a cellular service area that corresponds with a test- loading value. The amount of the additional required loading is the difference between the test- loading value and an actual loading value.
摘要翻译：一种射频收发器，其定义用于从所述RF收发器生成用于正交频分多址（OFDMA）RF传输的传输调度的调度逻辑，其中所述调度逻辑指定调制类型，码率，子信道和用于要在通信信号子帧中发送的多个符号的子载波。处理器根据传输时间表分别产生输出数据位和输出测试数据位，用于从RF收发器传输作为OFDMA传输信号和OFDMA测试数据传输信号，以在对应的蜂窝服务区域的至少一部分内创建负载具有测试加载值。额外所需负载的量是测试负载值与实际负载值之间的差值。

4. 发明申请

WO2008140585A1 APPARATUS AND METHOD FOR CONFORMAL MASK MANUFACTURING 审中-公开
标题翻译：用于一致性掩模制造的装置和方法
公开(公告)号：WO2008140585A1
公开(公告)日：2008-11-20
申请号：PCT/US2007/085447
申请日：2007-11-12
申请人： NEXGEN SEMI HOLDING, INC. , SCOTT, Jeffrey , ZANI, Michael , BENNAHMIAS, Mark , MAYSE, Mark
发明人： SCOTT, Jeffrey , ZANI, Michael , BENNAHMIAS, Mark , MAYSE, Mark
IPC分类号： G03F1/00 , G03C5/00 , H01L21/302
CPC分类号： H01J37/3174 , B82Y10/00 , B82Y40/00 , H01J37/3177 , H01L21/0331 , H01L21/0332 , H01L21/0337 , H01L21/26533 , H01L21/28123 , H01L21/30621 , H01L29/66659 , H01L29/7835 , Y10S430/143
摘要： A manufacturing process technology creates a pattern on a first layer using a focused ion beam process. The pattern is transferred to a second layer, which may act as a traditional etch stop layer. The pattern can be formed on the second layer without irradiation by light through a reticle and without wet chemical developing, thereby enabling conformal coverage and very fine critical feature control. Both dark field patterns and light field patterns are disclosed, which may enable reduced or minimal exposure by the focused ion beam.
摘要翻译：制造工艺技术使用聚焦离子束工艺在第一层上创建图案。该图案被转移到第二层，其可以用作传统的蚀刻停止层。该图案可以形成在第二层上，而不用光线通过掩模版进行照射，而不需要湿化学显影，从而实现适形覆盖和非常精细的关键特征控制。公开了两种暗场图案和光场图案，其可以实现聚焦离子束的减少或最小的曝光。

5. 发明申请

WO2021079195A1 TIM-3 INHIBITORS AND USES THEREOF 审中-公开
公开(公告)号：WO2021079195A1
公开(公告)日：2021-04-29
申请号：PCT/IB2020/000968
申请日：2020-10-20
申请人： NOVARTIS AG
发明人： VANASSE, K., Gary, J. , ELDJEROU, Lamis , MENSSEN, Hans , SCOTT, Jeffrey
IPC分类号： A61K31/706 , A61K39/395 , A61P35/02 , C07K16/28
摘要： Maintenance therapies comprising TIM-3 inhibitors are disclosed. The maintenance therapies can be used to treat cancerous conditions and disorders, including hematologic cancers. Maintenance therapies comprising TIM-3 inhibitors are also disclosed.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式